Boehringer Ingelheim Launches Metalyse® 25 mg in Egypt Following Approval by the Egyptian Drug Authority
Boehringer Ingelheim, a leading research-driven biopharmaceutical company, has announced the introduction of Metalyse® 25 mg (Tenecteplase) in Egypt as a treatment for acute ischemic stroke (AIS), following its recent approval by the Egyptian Drug Authority. Egypt is the second country
Egyptian Drug Authority, Sandoz discuss oncology drug localisation
The Chairperson of the Egyptian Drug Authority (EDA), Ali Ghamrawy, has met with a high-level delegation from Sandoz, a global pharmaceutical company, to discuss strengthening cooperation and localising the production of oncology drugs in Egypt. The Sandoz delegation was headed